help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 22, 2005
Endocrinology, doi:10.1210/en.2005-1073
A more recent version of this article appeared on April 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/4/1697    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, O. M.
Right arrow Articles by Jabbour, H. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, O. M.
Right arrow Articles by Jabbour, H. N
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on August 23, 2005
Accepted on December 13, 2005

Prostacyclin receptor upregulates the expression of angiogenic genes in human endometrium via cross talk with EGF receptor and the ERK 1/2 pathway

Oliver Milling Smith, Sharon Battersby, Kurt J Sales, Hilary OD Critchley, and Henry N Jabbour*

MRC Human Reproductive Science Unit (OPMS, SB, KJS and HNJ) and Department of Reproductive and Developmental Sciences (OPMS and HODC), The University of Edinburgh, Centre for Reproductive Biology, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, United Kingdom

* To whom correspondence should be addressed. E-mail: h.jabbour{at}hrsu.mrc.ac.uk.

Prostacyclin (PGI) is a member of the prostanoid family of lipid mediators that mediates its effects through a seven-transmembrane G protein-coupled receptor (IP receptor). Recent studies have ascertained a role for prostanoid-receptor signaling in angiogenesis. In this study we examined the temporal-spatial expression of the IP receptor within normal human endometrium and additionally explored the signaling pathways mediating the role of IP receptor in activation of target angiogenic genes. Quantitative RT-PCR analysis demonstrated highest endometrial expression of the IP receptor in the menstrual phase, compared with all other stages of the menstrual cycle. Immunohistochemical analysis localized the site of IP receptor expression to the glandular epithelial compartment with stromal and perivascular cell immunoreactivity. Expression of immunoreactive IP receptor protein was greatest during the proliferative and early secretory phases of the menstrual cycle. To explore the role of the IP receptor in glandular epithelial cells, we used the Ishikawa endometrial epithelial cell line. Stimulation of Ishikawa cells and human endometrial biopsy explants with 100 nM Iloprost (a PGI analog) rapidly activated ERK1/2 signaling and induced the expression of the pro-angiogenic genes; basic fibroblast growth factor, angiopoetin-1 and angiopoetin-2 in an epidermal growth factor receptor (EGFR)-dependent manner. Furthermore, EGFR co-localized with IP receptor in the glandular epithelial compartment. These data suggest that PGI-IP interaction within glandular epithelial cells can promote the expression of pro-angiogenic genes in human endometrium via cross talk with the EGFR.


Key words: prostaglandins • prostacyclin • cell signalling • angiogenesis




This article has been cited by other articles:


Home page
EndocrinologyHome page
S.-U. Chen, H. Lee, D.-Y. Chang, C.-H. Chou, C.-Y. Chang, K.-H. Chao, C.-W. Lin, and Y.-S. Yang
Lysophosphatidic Acid Mediates Interleukin-8 Expression in Human Endometrial Stromal Cells through Its Receptor and Nuclear Factor-{kappa}B-Dependent Pathway: A Possible Role in Angiogenesis of Endometrium and Placenta
Endocrinology, November 1, 2008; 149(11): 5888 - 5896.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
O.P.M. Smith, H.N. Jabbour, and H.O.D. Critchley
Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation
Hum. Reprod., May 1, 2007; 22(5): 1450 - 1456.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Battersby, K.J. Sales, A.R. Williams, R.A. Anderson, S. Gardner, and H.N. Jabbour
Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway
Hum. Reprod., January 1, 2007; 22(1): 36 - 44.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society